Harbor Capital Advisors Inc. Grows Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Harbor Capital Advisors Inc. grew its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 302.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 90,772 shares of the company’s stock after buying an additional 68,190 shares during the period. Harbor Capital Advisors Inc. owned 0.10% of Acadia Healthcare worth $3,599,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. State Street Corp raised its position in shares of Acadia Healthcare by 3.5% in the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after buying an additional 95,613 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after buying an additional 454,044 shares during the last quarter. LMR Partners LLP purchased a new stake in shares of Acadia Healthcare during the 3rd quarter valued at $1,616,000. Principal Financial Group Inc. grew its position in Acadia Healthcare by 2.1% in the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock worth $41,653,000 after acquiring an additional 13,368 shares in the last quarter. Finally, Sivik Global Healthcare LLC increased its stake in Acadia Healthcare by 43.7% in the third quarter. Sivik Global Healthcare LLC now owns 115,000 shares of the company’s stock valued at $7,292,000 after acquiring an additional 34,997 shares during the last quarter.

Acadia Healthcare Trading Down 0.4 %

NASDAQ ACHC opened at $44.92 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare Company, Inc. has a fifty-two week low of $36.50 and a fifty-two week high of $87.77. The stock has a market cap of $4.17 billion, a P/E ratio of 14.73, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The stock has a 50 day simple moving average of $40.48 and a two-hundred day simple moving average of $58.19.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. During the same quarter in the previous year, the business posted $0.91 earnings per share. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. On average, analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on ACHC shares. Royal Bank of Canada reiterated an “outperform” rating and set a $64.00 price objective on shares of Acadia Healthcare in a research report on Friday. Cantor Fitzgerald reissued a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a research note on Tuesday, December 10th. TD Cowen reduced their target price on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price target for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. Finally, KeyCorp upgraded Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective on the stock in a report on Tuesday. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.